Avantor, INC 10-K annual reports
Annual reports — audited financials, the full risk-factor list, and management’s account of the year.
NYSE
AVTR
Avantor, INCAvantor, Inc. reported a net loss of $530.2 million for fiscal year 2025, primarily driven by a significant goodwill impairment charge and declining net sales, despite a debt refinancing and cost transformation efforts.
NYSE
AVTR
Avantor, INCAvantor's 2024 10-K filing reveals a strategic shift towards Laboratory Solutions and Bioscience Production, alongside a cost transformation initiative aimed at $300 million in annual savings by 2026.
NYSE
AVTR
Avantor, INCAvantor, Inc.'s 2023 10-K filing reveals a 7.3% decrease in net sales and a strategic transition to two new business segments.